Teradyne (TER) Stock Looks Rich After A 272% Run

تيراداين إنك

Teradyne, Inc.

TER

0.00

Teradyne stock has delivered a very strong 272.2% return over the past year, yet its valuation checks lean expensive rather than cheap. This raises questions about how much of the recent optimism is already reflected in the price.

  • Over the last 1 year Teradyne has returned 272.2%, which puts extra focus on whether recent gains leave much room for further upside based purely on fundamentals.
  • Strong demand for Teradyne's AI related test equipment can support optimistic expectations, while any cooling in AI chip spending or a slowdown in semiconductor capital investment may weigh on the justification for the current share price.
  • Teradyne scores 2 out of 6 on the broader valuation checks, which suggests the stock does not screen as a clear bargain and may already carry a premium on several measures.

The issue now is whether Teradyne's current price leaves enough valuation headroom if growth or AI related demand soften from recent levels.

Does Teradyne Look Pricey on Earnings?

The P/E multiple is a useful way to look at Teradyne because earnings are a key focus for many investors in established semiconductor businesses. Teradyne currently trades at about 52.9x earnings. This is almost exactly in line with the wider semiconductor industry average of about 52.9x, and below the peer group average of 59.5x.

The fair P/E ratio implied by the broader checks is 44.4x, which sits meaningfully under Teradyne's current 52.9x. That gap suggests the stock prices in a richer valuation than the model would point to when it considers Teradyne's growth profile, margins, size and risk. Despite the recent strength in AI related test demand and upbeat earnings news, the current P/E still reflects a premium to this more tailored fair value yardstick.

On balance, Teradyne stock appears overvalued on the P/E multiple compared with the level suggested by the fair ratio model.

NasdaqGS:TER P/E Ratio as at Aug 2026
NasdaqGS:TER P/E Ratio as at Aug 2026

The Teradyne Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Teradyne pick up where this valuation puzzle leaves off and explain which assumptions about Teradyne's future growth, margins and earnings would need to hold for the stock to be worth materially more or less than today's price, using scenarios that sit on the Community page. Each one treats fair value as a thesis about how the business might progress that you can revisit over time, rather than a one off snapshot.

Community views on Teradyne sit far apart, with one camp seeing meaningful upside and another focused on downside risk if expectations reset.

Bull case: 12% undervalued

"Teradyne expects significant future growth potential from AI accelerators, robotics, and semiconductor automation, which are being driven by long-term industry themes such as AI, verticalization, and electrification..."

Bear case: 175% overvalued

"Teradyne's dependence on rapidly growing AI compute and cloud chip investment creates a significant risk that any slowdown or stall in AI infrastructure build-outs or a long-term deceleration in semiconductor innovation will yield sharply lower sales growth, impacting both future revenue and earnings..."

Do you think there's more to the story for Teradyne? Head over to our Community to see what others are saying!

The Bottom Line

Teradyne now screens as overvalued on the main market multiples, with the tailored fair ratio sitting below the current P/E. That does not rule out further gains, but it suggests the margin for error on expectations is tighter than before. The key question from here is whether demand for Teradyne's AI linked test and automation products can stay strong enough to support the current premium, or whether any easing in AI or semiconductor spending pushes investors to reassess the multiple they are willing to pay.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.